Variant report
Variant | nsv546419 |
---|---|
Chromosome Location | chr1:62650550-62656809 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:9)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:3)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:9 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | FOS | chr1:62650846-62651149 | MCF10A-Er-Src | breast: | n/a | n/a |
2 | FOS | chr1:62650894-62651146 | MCF10A-Er-Src | breast: | n/a | n/a |
3 | FOS | chr1:62650850-62651137 | MCF10A-Er-Src | breast: | n/a | n/a |
4 | FOS | chr1:62650847-62651145 | MCF10A-Er-Src | breast: | n/a | n/a |
5 | FOSL2 | chr1:62650869-62651164 | HepG2 | liver: | n/a | n/a |
6 | JUND | chr1:62650660-62651331 | SK-N-SH | brain: | n/a | chr1:62650988-62650999 |
7 | JUND | chr1:62650918-62651143 | HepG2 | liver: | n/a | chr1:62650988-62650999 |
8 | JUND | chr1:62650951-62651032 | H1-hESC | embryonic stem cell: | n/a | chr1:62650988-62650999 |
9 | MAX | chr1:62656643-62656653 | HepG2 | liver: | n/a | n/a |
No data |
No data |
(count:3 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-L1TD1-1 | chr1:62656194-62656598 | NONHSAT003628 |
2 | lnc-L1TD1-2 | chr1:62654803-62655175 | NONHSAT003627 |
3 | lnc-L1TD1-2 | chr1:62655541-62655625 | NONHSAT003627 |
No data |
No data |
Variant related genes | Relation type |
---|---|
RPS15AP7 | TF binding region |
L1TD1 | TF binding region |
PIGPP2 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1316323 | chr1:62650550-62650551 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs568870180 | chr1:62650591-62650592 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs552317368 | chr1:62650592-62650593 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs3066234 | chr1:62650593-62650594 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs528174542 | chr1:62650594-62650595 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs71752013 | chr1:62650604-62650605 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs76718430 | chr1:62650606-62650607 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs76871767 | chr1:62650607-62650608 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs149519040 | chr1:62650643-62650644 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs558465572 | chr1:62650655-62650656 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs377609136 | chr1:62650675-62650676 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs534239480 | chr1:62650702-62650703 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs555886660 | chr1:62650737-62650738 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs574154806 | chr1:62650745-62650746 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs1112561 | chr1:62650749-62650750 | Enhancers Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
16 | rs548046213 | chr1:62650769-62650770 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs145847843 | chr1:62650787-62650788 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs185953781 | chr1:62650789-62650790 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs577599468 | chr1:62650798-62650799 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs79543465 | chr1:62650821-62650822 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs142757126 | chr1:62650826-62650827 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs870906 | chr1:62650853-62650854 | Enhancers Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
23 | rs147340265 | chr1:62650881-62650882 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs191768698 | chr1:62650893-62650894 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs10637263 | chr1:62650920-62650921 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs35693102 | chr1:62650921-62650922 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs397758796 | chr1:62650930-62650931 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs147993842 | chr1:62650931-62650932 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs577755055 | chr1:62650951-62650952 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs142309931 | chr1:62650952-62650953 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs550643843 | chr1:62650992-62650993 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs569010255 | chr1:62651014-62651015 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs12031405 | chr1:62651018-62651019 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs183539662 | chr1:62651044-62651045 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs141571615 | chr1:62651060-62651061 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs111416336 | chr1:62651069-62651070 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs566482094 | chr1:62651183-62651184 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs150914497 | chr1:62651213-62651214 | Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
39 | rs555831668 | chr1:62651214-62651215 | Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
40 | rs372094804 | chr1:62651227-62651228 | Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
41 | rs139348026 | chr1:62651256-62651257 | Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
42 | rs533650197 | chr1:62651303-62651304 | Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
43 | rs538090465 | chr1:62651304-62651305 | Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
44 | rs556217853 | chr1:62651347-62651348 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs200600749 | chr1:62651391-62651392 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs577688138 | chr1:62651409-62651410 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs188241272 | chr1:62651415-62651416 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs527251378 | chr1:62651467-62651468 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs553712157 | chr1:62651490-62651491 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs191333952 | chr1:62651515-62651516 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Coronary Disease | 20032323 | CNVD |
Prostate cancer | 21965145 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Stargardt''s disease | 17277736 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-syndromic sensorineural hearing loss | 22290220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
Neuroblastoma | 17535989 | CNVD |
Pheochromocytoma | 17535989 | CNVD |
Prostate cancer | 16705090 | CNVD |
Astrocytoma | 17934521 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Chordoma | 21602918 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Melanoma | 18172304 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Melanoma | 17363583 | CNVD |
Cancer | 21129771 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 20409316 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21364760 | CNVD |
Rett syndrome | 21593744 | CNVD |
Breast cancer | 16620391 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16608533 | CNVD |
Ovarian cancer | 21720365 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
Breast cancer | 17133270 | CNVD |
Myelofibrosis | 22110671 | CNVD |
CNS Malformation Syndrome | 17530927 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Type 2 diabetes | 21956041 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Colorectal cancer | 20459617 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Medullary thyroid carcinoma | 18765511 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:62640600-62651200 | Enhancers | H1 Cell Line | embryonic stem cell |
2 | chr1:62646600-62660400 | Weak transcription | Right Atrium | heart |
3 | chr1:62649800-62651000 | Weak transcription | Placenta | Placenta |
4 | chr1:62649800-62660000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
5 | chr1:62650400-62651400 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
6 | chr1:62650400-62658400 | Weak transcription | H9 Cell Line | embryonic stem cell |
7 | chr1:62650400-62658800 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
8 | chr1:62651000-62651200 | Enhancers | Placenta | Placenta |
9 | chr1:62651400-62652000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
10 | chr1:62652000-62660200 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
11 | chr1:62656000-62657400 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
12 | chr1:62656800-62658600 | Weak transcription | H1 Cell Line | embryonic stem cell |